New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement

IHEvsIBBQETF Comparison

ETF 1
IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of
US Health Care
-1.03%
VS
ETF 2
IBBQ

Invesco Nasdaq Biotechnology ETF

This fund is part of
US Health Care
-1.03%

iShares U.S. Pharmaceuticals ETF (IHE) and Invesco Nasdaq Biotechnology ETF (IBBQ) belong to the same industry segment: US Health Care. IHE's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, IBBQ's top sector exposures are Healthcare and Non-Energy Materials. IHE is more expensive with a Total Expense Ratio (TER) of 0.37%, versus 0.19% for IBBQ. IHE is up 21.99% year-to-date (YTD) with +$500M in YTD flows. IBBQ performs better with 22.86% YTD performance, and +$38M in YTD flows. Run a side-by-side ETF comparison of IHE and IBBQ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IHE vs IBBQ performance and flow charts

Performance

-4.0-2.00.02.04.0%Sep 23Sep 30Oct 7Oct 14Oct 21

Cumulative Flows

-100 M-50 M0 MSep 23Sep 30Oct 7Oct 14Oct 21

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/23/2026
1M3MYTD1Y3Y5Y
Perf.
IHE
IBBQ
+1.25%-0.34%
+0.82%+7.21%
+21.99%+22.86%
+39.12%+36.10%
+87.20%+90.27%
+79.04%+44.83%
Flows
IHE
IBBQ
-$129M+$14M
+$77M+$35M
+$500M+$38M
+$664M+$56M
+$758M+$74M
+$754M+$52M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IHE
IBBQ
+18.62%+25.52%
+18.66%+22.48%
+17.25%+21.25%
+16.78%+22.22%
Max drawdown
IHE
IBBQ
-9.67%-8.58%
-9.67%-8.58%
-16.04%-23.78%
-16.12%-34.86%
Max drawdown duration
IHE
IBBQ
65d65d
65d65d
210d375d
669d1429d
Trading data

Create an account to view trading data

Join for free
IHE
IBBQ
Last sale
10/23/2026 at 1:30 PM
$102.51
$34.52
Previous close
10/22/2026
$104.78
$34.92
Consolidated volume
10/22/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IHE
IBBQ
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/23/2026 at 1:30 PM
Live
Closed
IHE
IBBQ
Last price
$102.51
$34.52
1D performance
-2.17%
-1.15%
AuM$1.54 B$115.07 M
E/R0.37%0.19%
Characteristics
IHE
IBBQ
Management strategyPassivePassive
ProvideriSharesInvesco
BenchmarkDow Jones U.S. Select Pharmaceuticals IndexNASDAQ Biotechnology Index
N° of holdings57249
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 1, 2006June 9, 2021
ESGNoNo
Advertisement
Exposure

Countries

IHE
USA
95.75%
Other
4.25%
IBBQ
USA
88.22%
Other
11.78%

Sectors

IHE
Healthcare
99.75%
Other
0.25%
IBBQ
Healthcare
99.99%
Other
0.01%
Advertisement

Diversification

IHE

Total weight of top 15 holdings out of 15

84.42%
IBBQ

Total weight of top 15 holdings out of 15

52.06%

Top 15 holdings

Data as of August 31, 2026
IHE
Johnson & Johnson
22.45%
Eli Lilly & Co.
20.50%
Merck & Co., Inc.
5.00%
Bristol Myers Squibb Co.
4.84%
Royalty Pharma Plc
4.54%
Pfizer Inc.
4.48%
Viatris, Inc.
4.19%
Zoetis, Inc.
3.82%
Jazz Pharmaceuticals Plc
3.43%
Elanco Animal Health, Inc.
2.61%
Corcept Therapeutics, Inc.
2.36%
Crinetics Pharmaceuticals, Inc.
1.95%
Axsome Therapeutics, Inc.
1.87%
Ligand Pharmaceuticals, Inc.
1.24%
Definium Therapeutics, Inc.
1.12%
IBBQ
Amgen, Inc.
8.60%
Vertex Pharmaceuticals, Inc.
8.10%
Gilead Sciences, Inc.
7.34%
Regeneron Pharmaceuticals, Inc.
5.26%
Moderna, Inc.
3.58%
Revolution Medicines, Inc.
2.97%
Illumina, Inc.
2.18%
Biogen, Inc.
2.07%
Alnylam Pharmaceuticals, Inc.
2.00%
argenx SE
1.84%
Royalty Pharma Plc
1.73%
Roivant Sciences Ltd.
1.71%
Insmed, Inc.
1.66%
Incyte Corp.
1.61%
United Therapeutics Corp.
1.42%
Frequently asked questions about IHE and IBBQ

How have the IHE and IBBQ ETFs performed in 2026?

As of October 23, 2026, IHE is up 21.99% year-to-date (YTD), while IBBQ has returned 22.86%. That puts IBBQ better performer ahead so far this year.

Which ETF is attracting more investor money: IHE or IBBQ?

Year-to-date, the IHE ETF saw +$500M in flows, compared to +$38M for IBBQ.

Which ETF is more volatile: IHE or IBBQ?

Over the past year, IHE had a volatility of 18.66%, while IBBQ experienced 22.48%.

Which ETF is bigger: IHE or IBBQ?

As of October 23, 2026, IHE holds $1.54 B in assets under management (AUM), while IBBQ manages $115.07 M.

What sectors do the IHE and IBBQ ETFs invest in?

IHE leans toward sectors like Healthcare. Meanwhile, IBBQ focuses on Healthcare.

What are the top holdings of the IHE ETF and IBBQ ETF?

IHE top holdings include Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc.. IBBQ holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc..

Which ETF is more diversified: IHE or IBBQ?

IHE holds 57 securities with 84.42% of its assets in the top 15. IBBQ has 249 securities and a top 15 weight of 52.06%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026